Timothy J Storms
Insider
First SEC filing: June 14, 2024 · Latest: June 14, 2024
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 13, 2024 | TCBIO | M | 109 | · | · | 4,509 Direct | -2.36% | Disposed | (price as of 2026-10-02) |
| June 13, 2024 | TCBIO | M | 65 | · | · | 2,673 Direct | -2.37% | Disposed | (price as of 2026-10-02) |
| June 13, 2024 | TCBIO | M | 31 | · | · | 1,261 Direct | -2.40% | Disposed | (price as of 2026-10-02) |
| June 13, 2024 | TCBIO | F | 205 | $55.92 | $11,464 | 16,366 Direct | -1.24% | Disposed | -66.2% (price as of 2026-10-02) |
| June 13, 2024 | TCBIO | M | 109 | · | · | 16,571 Direct | +0.66% | Acquired | (price as of 2026-10-02) |
| June 13, 2024 | TCBIO | M | 65 | · | · | 16,462 Direct | +0.40% | Acquired | (price as of 2026-10-02) |
| June 13, 2024 | TCBIO | M | 31 | · | · | 16,397 Direct | +0.19% | Acquired | (price as of 2026-10-02) |
| Feb. 26, 2024 | TCBIO | M | 3,043 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Feb. 26, 2024 | TCBIO | M | 3,544 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Feb. 26, 2024 | TCBIO | F | 744 | $58.06 | $43,197 | 16,366 Direct | -4.35% | Disposed | -67.4% (price as of 2026-10-02) |
| Feb. 26, 2024 | TCBIO | M | 3,043 | · | · | 17,110 Direct | +21.63% | Acquired | (price as of 2026-10-02) |
| Feb. 26, 2024 | TCBIO | F | 863 | $58.06 | $50,106 | 14,067 Direct | -5.78% | Disposed | -67.4% (price as of 2026-10-02) |
| Feb. 26, 2024 | TCBIO | M | 3,544 | · | · | 14,930 Direct | +31.13% | Acquired | (price as of 2026-10-02) |
| Feb. 16, 2024 | TCBIO | A | 4,618 | · | · | 4,618 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 16, 2024 | TCBIO | A | 9,236 | · | · | 9,236 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 9, 2024 | TCBIO | M | 1,368 | · | · | 2,738 Direct | -33.32% | Disposed | (price as of 2026-10-02) |
| Feb. 9, 2024 | TCBIO | F | 371 | $59.27 | $21,989 | 11,386 Direct | -3.16% | Disposed | -68.1% (price as of 2026-10-02) |
| Feb. 9, 2024 | TCBIO | M | 1,368 | · | · | 11,757 Direct | +13.17% | Acquired | (price as of 2026-10-02) |
| Feb. 8, 2024 | TCBIO | M | 1,292 | · | · | 1,292 Direct | -50.00% | Disposed | (price as of 2026-10-02) |
| Feb. 8, 2024 | TCBIO | F | 384 | $59.37 | $22,798 | 10,389 Direct | -3.56% | Disposed | -68.2% (price as of 2026-10-02) |
| Feb. 8, 2024 | TCBIO | M | 1,292 | · | · | 10,773 Direct | +13.63% | Acquired | (price as of 2026-10-02) |
| Feb. 9, 2023 | TCBIO | A | 4,106 | · | · | 19,715 Direct | +26.31% | Acquired | (price as of 2026-10-02) |
| Feb. 8, 2023 | TCBIO | F | 384 | $68.39 | $26,262 | 15,609 Direct | -2.40% | Disposed | -72.4% (price as of 2026-10-02) |
| Oct. 24, 2022 | TCBIO | P | 4,400 | $57.21 | $251,724 | 15,993 Direct | +37.95% | Acquired | -67.0% (price as of 2026-10-02) |
| Feb. 8, 2022 | TCBIO | A | 3,876 | · | · | 11,593 Direct | +50.23% | Acquired | (price as of 2026-10-02) |
| Sept. 2, 2021 | TCBIO | P | 4,173 | $59.83 | $249,671 | 7,717 Direct | +117.75% | Acquired | -68.4% (price as of 2026-10-02) |
| Feb. 26, 2021 | TCBIO | A | 3,544 | · | · | 3,544 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 13, 2024 | TCBIO | 2024 Restricted Stock Units | Common Stock | $0.00 | · | 109 | Disposed |
| June 13, 2024 | TCBIO | Restricted Stock Units | Common Stock | $0.00 | · | 65 | Disposed |
| June 13, 2024 | TCBIO | Restricted Stock Units | Common Stock | $0.00 | · | 31 | Disposed |
| Feb. 26, 2024 | TCBIO | 2021 Performance Stock Units | Common Stock | $0.00 | March 15, 2024 | 3,043 | Disposed |
| Feb. 26, 2024 | TCBIO | Restricted Stock Units | Common Stock | $0.00 | · | 3,544 | Disposed |
| Feb. 16, 2024 | TCBIO | 2024 Restricted Stock Units | Common Stock | $0.00 | · | 4,618 | Acquired |
| Feb. 16, 2024 | TCBIO | 2024 Restricted Stock Units | Common Stock | $0.00 | · | 9,236 | Acquired |
| Feb. 9, 2024 | TCBIO | Restricted Stock Units | Common Stock | $0.00 | · | 1,368 | Disposed |
| Feb. 8, 2024 | TCBIO | Restricted Stock Units | Common Stock | $0.00 | · | 1,292 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $423,750 | $250,000 | $414,535 | · | · | · | $12,225 | $1,674,260 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.